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I N T R O D U C T I O N
In skeletal muscle, excitation–contraction coupling (ECC) 
is initiated by the activation of the L-type Ca2+ channel 
or 1,4-dihydropyridine receptor (DHPR). The DHPR in 
turn activates Ca2+ release from the SR Ca2+ release chan-
nel (RYR type 1 [RYR1]). The communication between 
the two channels is rapid and does not require Ca2+ en-
try through the DHPR, and it is believed that there is a 
physical interaction between the two proteins (Armstrong 
et al., 1972; Tanabe et al., 1990; Dirksen and Beam, 
1999). In addition to the “orthograde” signal that triggers 
gating of RYR1, a “retrograde” signal from RYR1 to the 
DHPR was revealed by the observation that L-type cur-
rents of dyspedic (RYR1-null) myotubes were substan-
tially smaller than L-type currents of wild-type (WT) 
myotubes, despite similar surface membrane expression 
of the L-type channel (Nakai et al., 1996).
Correspondence to Paul D. Allen: allen@­z­eus.bwh.harvard.edu
Abbreviations used in this paper: DHPR, 1,4-dihydropyridine receptor; 
ECC, excitation–contraction coupling; Het, heteroz­ygous; Hom, homoz­y-
gous; MH, malignant hyperthermia; MHS, MH-susceptible WT, wild-type.
Malignant hyperthermia (MH) is a fulminant pharma-
cogenetic life-threatening syndrome, which occurs when 
susceptible individuals are exposed to triggering factors, 
which include halogenated inhalation anesthetics and/or 
depolariz­ing muscle relaxants like succinylcholine (López­ 
et al., 1985, 1988; Nelson, 2001, 2002; Treves et al., 2005). 
The syndrome is associated with massive increases in intra-
cellular Ca2+ ([Ca2+]i) in response to exposure to the trig-
gering agent (López­ et al., 1988). ECC dysfunction is 
believed to be the underlying cause of MH susceptibil-
ity because of its linkage in humans to more than 122 
mutations within 19q13, the gene that codes for RYR1 
(Robinson et al., 2006), or two characteriz­ed mutations 
within 1q31-32, the gene that codes CaV1.1 (Monnier 
et al., 1997; Jurkat-Rott et al., 2000). MH-susceptible 
(MHS) pigs and mice possessing a missense mutation 
(R614C [pigs] and R163C or Y522S [knock-in mice]) in 
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Bidirectional signaling between the sarcolemmal L-type Ca2+ channel (1,4-dihydropyridine receptor [DHPR]) and 
the sarcoplasmic reticulum (SR) Ca2+ release channel (type 1 ryanodine receptor [RYR1]) of skeletal muscle is es-
sential for excitation–contraction coupling (ECC) and is a well-understood prototype of conformational coupling. 
Mutations in either channel alter coupling fidelity and with an added pharmacologic stimulus or stress can trigger 
malignant hyperthermia (MH). In this study, we measured the response of wild-type (WT), heteroz­ygous (Het), or 
homoz­ygous (Hom) RYR1-R163C knock-in mouse myotubes to maintained K+ depolariz­ation. The new findings 
are: (a) For all three genotypes, Ca2+ transients decay during prolonged depolariz­ation, and this decay is not a con-
sequence of SR depletion or RYR1 inactivation. (b) The R163C mutation retards the decay rate with a rank order 
WT > Het > Hom. (c) The removal of external Ca2+ or the addition of Ca2+ entry blockers (nifedipine, SKF96365, 
and Ni2+) enhanced the rate of decay in all genotypes. (d) When Ca2+ entry is blocked, the decay rates are slower 
for Hom and Het than WT, indicating that the rate of inactivation of ECC is affected by the R163C mutation and 
is genotype dependent (WT > Het > Hom). (e) Reduced ECC inactivation in Het and Hom myotubes was shown 
directly using two identical K+ depolariz­ations separated by varying time intervals. These data suggest that confor-
mational changes induced by the R163C MH mutation alter the retrograde signal that is sent from RYR1 to the 
DHPR, delaying the inactivation of the DHPR voltage sensor.
© 2010 Estève et al. This article is distributed under the terms of an Attribution–Noncom-
mercial–Share Alike–No Mirror Sites license for the first six months after the publication 
date (see http://www.rupress.org/terms). After six months it is available under a Creative 
Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de-
scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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620 MH RYR1 mutations influence DHPR function
Experimental protocols for Ca2+ transients
WT, R163C Het, or Hom R163C myotubes were exposed to high 
external potassium ([K+]e) solutions in ascending or descending 
concentrations (10, 20, 40, and 60 mM KCl) for 180 s for each 
concentration separated by 180 s of rest. The concentration of 
60 mM K+ was chosen for the remaining experiments because we 
have found that this concentration of K+ elicits a maximum Ca2+ 
response in skeletal muscle myotubes (Yang et al., 2007a). WT 
and Hom R163C myotubes were exposed to 20 mM caffeine for 
10 s, and 180 s later to 60 mM [K+]e for 180 s. During the 180-s 
period that the cell was depolariz­ed, a second 10-s application of 
20 mM caffeine was applied at intervals ranging from 20 to 200 s 
after the beginning of the 60-mM [K+]e application. WT and 
R163C myotubes were exposed to 60 mM [K+]e in the presence of 
1.8 × 103 M Ca2+ (normal Ca2+) or 8.7 × 106 M Ca2+/5 mM Mg2+ 
(low Ca2+) solutions. The exposure to the low Ca2+ solution was 
done for 10 s before depolariz­ation with 60 mM [K+]e. WT and 
Hom R163C myotubes were exposed either to 10 µM nifedipine 
or 20 µM SKF-96365 for 10 s before depolariz­ation with 60 mM 
[K+]e. This time was chosen to minimiz­e any effect on the am-
plitude of the Ca2+ transient that we observed with longer incu-
bation times. WT and R163C Het and Hom myotubes were 
exposed to 60 mM [K+]e first with normal Ca2+ solution, allowed 
to recover for 10 min, then with low Ca2+ solution, allowed to 
recover for 10 min, and then finally with low Ca2+ solution sup-
plemented with 2 mM [Ni2+]e; the responses were compared. 
WT and R163C Het and Hom myotubes were exposed to 60 mM 
[K+]e for 10 s, and then the Ca2+ transient was interrupted by re-
placing the high [K+]e solution with normal mammalian Ring-
er’s solution, followed by a second application of 60 mM [K+]e 
3, 5, or 10 s later.
Manganese quench
Differentiated primary WT or R163C Hom myotubes were 
loaded with 5 mM Fura-2 AM (Invitrogen) for 30 min at 37°C 
and washed four times for 10 min, each time in imaging buffer. 
After a baseline was established, the external solution was 
switched to a Ca2+-free buffer containing a final concentration 
of 500 µM Mn2+ (in the presence of 5 mM external Mg2+) with 
or without the addition of 2 mM Ni2+, and then stimulated with 
60 mM KCl. The cells were continuously imaged before and af-
ter KCl stimulation at an excitation wavelength of 360 ± 3 nm 
(the isosbestic point of Fura-2), and fluorescence intensity was 
monitored with a 510-nm long-pass filter through a 40× quartz­ 
objective using an intensified CCD camera (see above). Data 
were collected from 3–10 individual cells simultaneously at 15 
frames per second. The upward deflection that is seen in all 
raw traces shown indicates the application of KCl and is an ar-
tifact caused by intracellular Ca2+ release because it is not pos-
sible to be precisely at the isosbestic point of Fura-2 using any 
filter system.
Solutions
The composition of standard Ringer’s solution was (in mM): 
125 NaCl, 5 KCl, 2 CaCl2, 1.2 MgSO4, 5 glucose, and 25 HEPES, 
pH 7.4. Pilot experiments were conducted with Het and Hom 
R163C and WT myotubes exposed to [K+]e solutions in which 
the [K+] × [Cl] was either maintained constant or not main-
tained constant. No significant difference was observed in the 
amplitude and kinetics of the Ca2+ transients elicited by the 
high K+ solutions under either condition; therefore, we did not 
maintain the [K+] × [Cl] in the solutions used experimentally 
(Hodgkin and Horowicz­, 1959). The NaCl concentrations were 
adjusted to maintain a total ionic strength [Na+] + [K+] con-
stant at 130 mM. Caffeine was prepared by adding the desired 
amount directly into the Ringer’s solution or the correspond-
ing high [K+]e solutions.
RYR1 develop fulminant episodes when exposed to trig-
gering agents and heat stress (López­ et al., 1988; Chelu 
et al., 2006; Yang et al., 2006). In addition, there is evi-
dence that the R163C mutation not only influences 
RYR1 channel properties (Yang et al., 2003, 2006), but 
also potentiates depolariz­ation-induced Ca2+ entry 
(Cherednichenko et al., 2004, 2008; Yang et al., 2007b). 
However, exactly how MHS mutations potentiate de-
polariz­ation-induced Ca2+ entry and modify important 
aspects of orthograde and retrograde signaling between 
DHPR and RYR1 is poorly understood.
In the present study, we have examined how an MH 
mutation in RYR1 (R163C) affects the voltage depen-
dence, time course, and extracellular Ca2+ dependence 
of the Ca2+ transient during prolonged depolariz­ation 
induced by high extracellular K+. In doing so, we dem-
onstrate that the R163C mutation alters retrograde 
signaling between RYR1 and the DHPR, as manifested 
by delayed inactivation of the DHPR voltage sensor, 
and at this level of depolariz­ation enhances sarcolem-
mal Ca2+ entry.
M AT E R I A L S  A N D  M E T H O D S
Generation of primary myotubes
Primary myoblast cell lines were generated from the hind limb 
and forelimb muscles of neonatal heteroz­ygous (Het) and ho-
moz­ygous (Hom) F2 R163C C57Bl6/129svJ mice and their WT 
littermates (Rando and Blau, 1994; Yang et al., 2006). Myo-
blasts were differentiated into myotubes by withdrawal of 
growth factors as described previously (Yang et al., 2003). Ani-
mals were housed, fed, and sacrificed according to the stan-
dards set by the Harvard Medical School Institutional Animal 
Care and Use Committee.
Ca2+ imaging
Differentiated WT and R163C myotubes were loaded with 5 µM 
Fluo-4-AM (Invitrogen) at 37°C for 30 min in mammalian Ring-
er’s solution as described previously (Yang et al., 2006). The 
myotubes were then washed several times with mammalian 
Ringer’s solution and transferred to a microscope (Nikon). Fluo-
rescence emission was measured at 516 nm with a long-pass fil-
ter using a 40×, 1.3 NA objective lens. Data were collected with 
a 12-bit digital-intensified CCD at 23 fps (Mega12; Stanford Pho-
tonics) from regions consisting of 8–12 individual cells per well 
and analyz­ed using QED software (QED Imaging). The mag-
nitude of integrated Ca2+ transient (defined by the average area 
under the Ca2+ transient during a 3-min depolariz­ation elicited 
by elevating [K+] in the extracellular medium) was compared 
among genotypes.
Intracellular recording
Single-barrel capillary tubing (1.5 mm OD; TW150F-4; WPI) con-
taining an internal filament was used in the construction of mi-
croelectrodes for measuring the resting membrane potential. 
The pipettes were backfilled with 3 M KCl (resistance of 15 M) 
and used to impale individual WT and R163C myotubes to mea-
sure membrane potential (at room temperature) before and dur-
ing the time that myotubes were incubated in 60 mM K+ for 180 s. 
Results were discarded if tip resistance was altered by cell mem-
brane penetration or from myotubes with resting potential values 
less negative than 60 mV.
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To make certain that membrane depolariz­ation evoked 
by 60 mM [K+]e was maintained at similar potentials 
among the myotubes used in the study, the membrane 
potential was recorded from each genotype before and 
during the 180-s depolariz­ation. There was no signifi-
cant difference (P > 0.05, nonpaired t test) in resting 
membrane potentials or potentials obtained during the 
60-mM [K+]e challenge, and the level of depolariz­ation 
was sustained for the duration of the [K+]e test, regard-
less of the myotube’s genotype (Table I).
Decay of the Ca2+ transient during prolonged 
depolarization is not due to SR Ca2+ depletion  
or RYR1 inactivation
To test the hypothesis that the spontaneous decay of the 
K+-evoked Ca2+ transients was the result of SR Ca2+ de-
pletion or inactivation of RYR1 by high myoplasmic Ca2+ 
concentrations, we elicited SR Ca2+ release with a 10-s 
application of 20 mM caffeine before, during, and after 
exposure to 60 mM [K+]e. Fig. 2 shows the response to 
caffeine at different intervals (20, 40, 80, 120, 160, and 
200 s) after initiating a 180-s challenge to 60 mM [K+]e. 
At each interval, caffeine produced a robust release of 
Ca2+ whose amplitude was not significantly different 
(P > 0.1) than that measured before the [K+]e challenge, re-
gardless of genotype. Thus, decay of the [K+]e-triggered 
Ca2+ transient in WT and Hom R163C myotubes does 
not appear to be related to either depletion of SR Ca2+ 
stores (Hodgkin and Horowicz­, 1960b) or inactivation 
of RYR1 (Smith et al., 1985; Suarez­-Isla et al., 1986; 
Simon et al., 1991; Jong et al., 1995).
Removal of external Ca2+ accelerates Ca2+ transient decay
It is well established that a relatively short exposure to 
a low [Ca2+]e medium has no effect on the peak K+ 
Statistical analysis
All values are expressed as mean ± SEM, with the numbers in pa-
rentheses indicating the number of myotubes tested. Statistical 
analysis was performed using paired t test, unpaired t test, or one-
way analysis of variance coupled with Tukey’s t test for multiple 
measurements to determine significance (P < 0.05). Rates of de-
cay were calculated using the formula y(t) = aekt.
R E S U LT S
The MH-causing R163C RyR1 mutation slows the decay  
of Ca2+ transients during prolonged depolarization
Fig. 1 shows representative Ca2+ transients elicited from 
WT and R163C Het and Hom myotubes by a random 
order titration of [K+]e (10, 20, 40, and 60 mM). The K+-
evoked Ca2+ transients from the myotubes of all three 
genotypes had a magnitude and time course that was 
dependent on [K+]e. The threshold [K+]e needed to 
elicit Ca2+ transients was 10 mM for Het and Hom R163C 
myotubes, whereas it was 20 mM in WT cells (P < 0.05, 
Tukey’s multiple tests; Fig. 1). Independent of the [K+]e 
concentration, the integrated magnitude of the Ca2+ 
transients showed the rank order as Hom >> Het > WT. 
WT and R163C myotubes respond to prolonged [K+]e 
exposures with an initial brief Ca2+ peak followed by a 
spontaneous exponential decay. This spontaneous decay 
was seen in all myotubes tested, despite the fact that de-
polariz­ation of the plasma membrane was maintained 
throughout the exposure. At the maximum [K+]e concen-
tration tested (60 mM), the average integrals of the Ca2+ 
transients were 1.8 and 3.6 times greater in Het and Hom 
R163C myotubes in relation to WT myotubes, and the 
peak rates of Ca2+ transient decay were 0.107 ± 0.004 s1 
(n = 11), 0.068 ± 0.004 s1 (n = 13), and 0.037 ± 0.003 s1 
(n = 17) in WT and R163C Het and Hom myotubes, re-
spectively (P < 0.001).
Figure 1. K+ dose response 
for WT and R163C Het and 
Hom myotubes. Representa-
tive fluorescence imaging re-
cords of WT and R163C (Het 
and Hom) myotubes loaded 
with Fluo-4 AM exposed to 
10, 20, 40, and 60 mM [K+]e 
for 180 s to observe the entire 
time course of the Ca2+ tran-
sients. The peak of the Ca2+ 
transients increased and the 
duration shortened as [K+]e 
was elevated from 10 to 60 mM 
in all three genotypes. Afu, 
arbitrary fluorescence units.
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WT, 74 ± 7% (n = 14) in Het R163C, and by 80 ± 9.3% 
(n = 12) in Hom R163C in low [Ca2+]e solution, and the 
rate of Ca2+ decay was increased from 0.107 ± 0.004 s1  
(n = 11) to 0.233 ± 0.006 s1 (n = 9), from 0.068 ± 0.004 s1 
(n = 13) to 0.144 ± 0.004 s1 (n = 14), and from 0.037 ± 
0.003 s1 (n = 17) to 0.137 ± 0.005 s1 (n = 12) in WT, 
Het, and Hom, respectively. The changes in the tran-
sient integral and rate of decay were fully reversible in a 
third depolariz­ation for all genotypes, when [Ca2+]e was 
restored in the bath solution (unpublished data).
Effect of Ca2+ entry blockers on K+-induced Ca2+ transients
Because removal of external Ca2+ would be expected 
not only to eliminate Ca2+ entry, but also to accelerate 
inactivation of the voltage sensor for ECC (Rios and 
Brum, 1987), we also examined the effect of two organic 
Ca2+ entry blockers, nifedipine and SKF-96365 (Almers 
and Palade, 1981; Rivet et al., 1989; Leung and Kwan, 
1999; Araya et al., 2003; Bannister et al., 2009), in the 
presence of Ca2+ replete external solutions.
Exposure to 10 µM nifedipine in the presence of nor-
mal external Ca2+ concentrations did not affect Ca2+ 
transient amplitude, but it accelerated the mean rate of 
decay from 0.107 ± 0.004 s1 (n = 11) to 0.135 ± 0.005 s1 
(n = 11) in WT (30%), and from 0.037 ± 0.003 s1 (n = 17) 
to 0.117 ± 0.002 s1 (n = 16) in Hom R163C (70%) 
myotubes (P < 0.001; Fig. 4 A). Exposure of WT and 
Hom R163C myotubes to 20 µM SKF-96365 did not 
lower Ca2+ transient amplitude, but it accelerated the 
mean rate of decay from 0.107 ± 0.004 s1 (n = 11) to 
0.146 ± 0.005 s1 (n = 9) in WT myotubes (27%), and 
from 0.037 ± 0.003 s1 (n = 17) to 0.072 ± 0.004 s1 (n = 13) 
in Hom R163C (49%) myotubes (P < 0.001; Fig. 4 B). 
To test whether the effects of nifedipine or SKF96365 
on the decay rate of the Ca2+ transients could be explained 
contracture tension; however, it greatly shortens the 
contracture time course, reducing the duration of the 
plateau and increasing the relaxation rate (Bianchi and 
Shanes, 1959; Frank, 1960; Caputo and Gimenez­, 1967). 
Recently, the L-type current has been identified as the 
major means of Ca2+ entry during prolonged depolar-
iz­ations or repetitive activity (Bannister and Beam, 2009; 
Bannister et al., 2009). Such Ca2+ entry is enhanced in 
both Het and Hom R163C myotubes in response to 
[K+]e depolariz­ation and electrical pulse trains (Yang 
et al., 2007a; Cherednichenko et al., 2008). Here, we have 
examined the impact of the R163C mutation on exter-
nal Ca2+ effects in more detail. Exposure of WT and Het 
and Hom R163C myotubes to low Ca2+ solution (8.7 × 106 
M/5 mM Mg2+) did not modify initial Ca2+ peak, but it 
dramatically altered the time course of the Ca2+ tran-
sients, making their duration shorter and their rate of 
decay faster in all three genotypes (Fig. 3). The integral 
of the Ca2+ transient was reduced by 62 ± 5.8% (n = 9) in 
TA B L E  I
Membrane potentials of WT and R163C Het and Hom mouse myotubes 
at rest and during depolarization with 60 mM [K+]e
Treatment and genotype Membrane potential n
mV
Normal Ringer’s solution
WT 63.6 ± 0.39 13
Het R163C 63.5 ± 0.42 10
Hom R163C 63.8 ± 0.5 10
60 mM KCl
WT 13.8 ± 1.4 13
Het R163C 14.6 ± 1.3 13
Hom R163C 12.6 ± 1.2 11
Values are expressed as mean ± SE.
Figure 2. Decay of the Ca2+ transient is not 
due to store depletion or to RYR1 inactivation. 
Representative fluorescence records of WT and 
Hom R163C myotubes loaded with Fluo-4 AM in 
response to a 10-s exposure to 20 mM caffeine 
(Caf) and a 180-s exposure to 60 mM [K+]e, fol-
lowed by a second 10-s application of 20 mM caf-
feine (*) applied at different intervals (20–200 s) 
after the Ca2+ transient was elicited by 60 mM 
[K+]e. The decay of the Ca2+ transient during K+ 
depolariz­ation does not appear to be related to 
SR Ca2+ depletion, nor is it due to RYR1 inactiva-
tion based on the amplitude of the second caf-
feine response (*).
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The reduced rate of ECC voltage sensor inactivation  
that results from the R163C mutation is apparent when 
Ni2+ is substituted for Ca2+
Although both nifedipine and SKF-96365 accelerated 
Ca2+ transient decay, the decay rates remained different 
between WT and Hom myotubes, providing further sup-
port for the hypothesis that the R163C mutation affects 
the rate at which the DHPR transitions into the ECC-
 inactivated state. To further test this hypothesis, we ex-
amined the effect of replacement of external Ca2+ by 
Ni2+. Previous investigations in amphibian muscle have 
shown that when Ni2+ is used to replace Ca2+ in the extra-
cellular medium, the normal time course of K+ contrac-
tures is maintained (Caputo, 1981; Lorković and Rüdel, 
1983), despite the fact that Ni2+ blocks Ca2+ current con-
ducted by amphibian skeletal L-type channels (Almers 
and Palade, 1981; Obejero-Paz­ et al., 2008). Fig. 5 shows 
superimposed averaged records from experiments in 
which WT and R163C Het and Hom myotubes were ex-
posed to 60 mM [K+]e under three different experimen-
tal conditions: in the presence of (1) 1.8 × 103 M Ca2+, 
(2) 8.7 × 106 M Ca2+, and (3) 8.7 × 106 M Ca2+ supple-
mented with 2 × 103 M Ni2+ (see Materials and methods 
for details). As shown above, the removal of Ca2+ signifi-
cantly accelerated the rate of decay compared with the 
response in normal Ca2+ solutions. Importantly, the addi-
tion of Ni2+ to low [Ca2+]e solutions also resulted in pro-
longation of the K+-evoked Ca2+ transients in WT, Het, 
and Hom myotubes, although it did not restore the rate 
of decay to control levels. Under all three conditions, 
the decay rate was significantly slower in Hom and Het 
myotubes compared with WT. If the decay rates of the 
Ca2+ transients in the presence of Ni2+ are taken to indi-
cate the normal course of SR Ca2+ release without any in-
fluence from Ca2+ entry, the fraction of the total Ca2+ 
release that is presumably due to the inactivation of the 
DHPR caused by the lack of extracellular Ca2+ was 35.7% 
of the area under the curve in WT, 44.1% in Het R163C, 
and 64.3% in Hom R163C myotubes. These results 
by their ability to partially depolariz­e the myotubes’ 
membrane at rest, or affect a change in the magnitude of 
the depolariz­ation induced by 60 mM [K+]e, membrane 
potentials were measured directly under these experi-
mental conditions. Neither nifedipine nor SKF-96365 
modified the resting membrane potential or the ability 
of 60 mM [K+]e to depolariz­e the myotubes to the ex-
pected membrane potential (unpublished data).
Figure 3. Low [Ca2+]e increases the rate of decay of the Ca2+ tran-
sient in response to 60 mM [K+]e. The average transients obtained 
from WT and R163C Het and Hom myotubes exposed to 60 mM 
[K+]e for 3 min in normal [Ca2+]e and in low [Ca2+]e solution (no 
added Ca2+ and no EGTA). Data were normaliz­ed by making the 
peak transient of each response equal to 1.
Figure 4. The effect of nifedipine and SKF-96365 
on the decay of the K+-induced Ca2+ transients. 
The average normaliz­ed traces (n = 8–10) of Ca2+ 
transients from WT and Hom R163C myotubes 
in response to 60 mM [K+]e for 180 s before and 
after exposure to 10 µM nifedipine (A) or 20 µM 
SKF96365 (B). The cells were exposed to nifedi-
pine or SKF96365 for 10 s before and throughout 
the K+ depolariz­ation.
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Double K+ pulse protocol to assess DHPR voltage sensor 
inactivation
Depolariz­ation converts resting DHPR voltage sensors 
into their active state, after which they spontaneously 
change conformation and transition into their inac-
tive state. The amount of SR Ca2+ release in response 
to depolariz­ation is proportional to the degree that 
the voltage sensors are in their active state (Dulhunty 
and Gage, 1988; Dulhunty, 1992), when the T-tubule 
is depolariz­ed. WT and R163C Het and Hom myo-
tubes were initially exposed to 60 mM [K+]e for 10 s 
(Fig. 7, Int1), and then returned to normal mamma-
lian Ringer’s solution for 3, 5, or 10 s (Fig. 7, t), and 
then reexposed to 60 mM [K+]e for 10 s (Fig. 7, Int2). 
We observed that washout of the elevated K+ solution 
with normal Ringer’s solution immediately stopped 
the Ca2+ transient in all three genotypes, an effect that 
can be attributed to the repolariz­ation of the plasma 
membrane. However, the amplitude of the Ca2+ tran-
sient triggered by reexposure to high [K+]e was highly 
genotype dependent (Fig. 7, Int2). The integral of the 
Ca2+ transient during lnt2 in Hom R163C myotubes 
was not significantly different from the integral dur-
ing Int1 for all interpulse intervals (Fig. 7; P > 0.05, 
Tukey’s multiple tests). In Het R163C myotubes, lnt2 
was significantly smaller than Int1 at 3 s, but not signif-
icantly different from Int1 at 5 and 10 s (Fig. 7). In WT 
myotubes, on the other hand, Int2 was significantly 
lower than Int1 at all three intervals tested (i.e., 3, 5, 
and 10 s; P < 0.001). These results indicate that the 
DHPR voltage sensor inactivates more slowly in MHS 
myotubes than in WT.
suggest that the shortening of the Ca2+ transient in low 
Ca2+ solution was a combined consequence of accelerated 
inactivation of the DHPR voltage sensor and decreased 
depolariz­ation-induced Ca2+ entry (see Table II for decay 
rates). Furthermore, these data show that the lack of extra-
cellular Ca2+ affects the inactivation of the DHPR ECC 
voltage sensor in the Het and Hom R163C myotubes to a 
much greater extent than in WT myotubes.
Cation entry is enhanced by R163C and can be  
blocked by Ni2+
We directly measured the differences in cation entry 
in response to membrane depolariz­ation using the Mn2+ 
quench technique in Hom R163C and WT myotubes. 
Fig. 6 A shows representative Fura-2 emission traces 
from Hom R163C and WT myotubes before and after 
stimulation with 60 mM KCl in the presence and ab-
sence of Ni2+. As summariz­ed in Fig. 6 B, these data 
show the average rate of Mn2+ quench measured during 
the linear phase of quench after KCl exposure was sig-
nificantly greater in Hom R163C myotubes than in WT 
myotubes (P < 0.01). Furthermore, cation entry was al-
most completely abolished in both groups of myotubes 
by the addition of 5 mM Ni2+.
Figure 5. Ni2+ partially reverses the effect of low 
[Ca2+]e on the Ca2+ transient. The average normal-
iz­ed Ca2+ transients from WT (n = 14), Het (n = 12), 
and Hom (n = 18) R163C myotubes, which were de-
polariz­ed for 180 s by 60 mM [K+]e in the presence of 
1.8 × 103 M Ca2+, followed by a 5-min rest in normal 
Ringer’s solution, depolariz­ed for 180 s again in low 
Ca2+ solution (3.7 × 106 M), followed by a second 
5-min rest, and then depolariz­ed for a third time in 
low Ca2+ solution supplemented with 2 × 103 M Ni2+ 
(see Table II for the rates of Ca2+ transient decay for 
each condition).
TA B L E  I I
Effect of Ni2+ on the rate of Ca2+ transient decay (s1)
Genotype Low Ca2+ n Low Ca2+ and Ni2+ n
WT 0.223 ± 0.006 10 0.139 ± 0.004 10
Het R163C 0.144 ± 0.004 13 0.085 ± 0.003 13
Hom R163C 0.137 ± 0.004 14 0.049 ± 0.002 13
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the Ca2+ transient was greatly prolonged at low [K+]e. 
Although the peak amplitude of the Ca2+ transient was 
enhanced with increasing [K+]e, the duration of the 
transient decreases. The inverse relationship between 
[K+]e and transient duration is related to the rate of in-
activation of the voltage sensor of the DHPR (Caputo 
and Bolaños, 1994).
In agreement with previous work on dyspedic myo-
tubes expressing RYR1 with any of seven MH-causing 
mutations (Yang et al., 2003, 2007a), we found in the 
present work that elevated K+ produced Ca2+ transients 
in primary R163C myotubes, which activated at lower 
membrane potentials and decayed more slowly than 
in WT myotubes. Thus, these alterations of Ca2+ han-
dling may be a common consequence of many MH mu-
tations of RYR1. These observations are in agreement with 
those reported by Gallant and co-workers (Gallant et al., 
1982; Gallant and Lentz­, 1992), in which the mechanical 
D I S C U S S I O N
There is general agreement that membrane depolariz­a-
tion elicited by high [K+]e triggers intracellular Ca2+ tran-
sients in amphibian (Blinks et al., 1978; López­ et al., 1983; 
Snowdowne, 1985; Caputo and Bolaños, 1994) and mam-
malian skeletal muscle (López­ et al., 2005). Exposure of 
WT and R163C myotubes to prolonged high [K+]e trig-
gered Ca2+ transients characteriz­ed by a peak Ca2+ tran-
sient that varied with [K+]e and subsided over time, despite 
the fact that the membrane remained depolariz­ed.
As has been shown previously, the duration and the 
peak amplitude of a K+ contracture (Hodgkin and 
Horowicz­, 1960b) or the corresponding Ca2+ transient 
(Caputo and Bolaños, 1994) depend on the [K+]e and 
hence on membrane potential. The results of the pres-
ent study confirm these essential features in all three 
genotypes studied (Fig. 1). Thus, the peak amplitude 
of the Ca2+ transient was smaller and the duration of 
Figure 6. Mn2+ quench in WT 
and Hom R163C myotubes in the 
absence and presence of 2 mM 
Ni2+. (A) Representative Fura-2 
emission traces from WT and 
R163C Hom myotubes before and 
after stimulation with 60 mM KCl 
in the presence and absence of 
Ni2+. (B) The average rates ± SEM 
of Mn2+ quench during the lin-
ear phase of quench after KCl 
exposure with (left) and without 
(right) the addition of Ni2+ to the 
bath solution. *, P < 0.01.
Figure 7. Inactivation of the DHPR 
voltage sensor is genotype depen-
dent. Representative Ca2+ transients 
for WT (A), Het (B), and Hom (C) 
myotubes induced by the following 
protocol: 60 mM [K+]e (Int1) for 10 s; 
2.5 mM [K+]e for 3, 5, or 10 s; 
60 mM [K+]e (Int2). (D) The inte-
grals of the second Ca2+ transient 
were expressed as a percentage 
of the first fluorescence signal 
(**, P < 0.01; Tukey’s test for mul-
tiple comparisons). The amplitude 
of the second Ca2+ transient was 
used as an index of DHPR inactiva-
tion at the time the second stimulus 
was applied.
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Ca2+ content was reduced by the lower [Ca2+]e, the peak 
amplitude (early phase) of the Ca2+ transient during 
long depolariz­ation would have also been reduced. Be-
cause a reduction in peak transient amplitude was not 
observed in our experiments on intact myotubes, it ap-
pears that SR Ca2+ stores were not significantly reduced 
by exposure to lower [Ca2+]e. This also argues against 
the alternative explanation that the slower rate decay in 
R163C compared with WT could have been due to 
changes in electrical properties of the myotubes during 
high [K+]e exposure, as was reported in amphibian mus-
cle fibers (Stefani and Chiarandini, 1973). If this were 
the case, the peak transient amplitude would also be re-
duced (Fig. 1). The most likely explanation is that the 
main alteration caused by low [Ca2+]e is an inactivation 
of the voltage sensor and a reduction in SR Ca2+ release 
with no change in the rate of Ca2+ removal from the 
myoplasm (Brum et al., 1988). The suggested mecha-
nism for this is the existence of a high affinity Ca2+ bind-
ing site or sites on the external side of the DHPR (Ebata 
et al., 1990), which modulate its inactivation process 
(Rios and Brum, 1987). In addition, the removal of ex-
ternal Ca2+ compromises the Ca2+ entry, which sustains 
the time course of the Ca2+ transients in WT and R163C 
myotubes, induced by [K+]e depolariz­ation and long 
trains of electrical stimuli (Cherednichenko et al., 2004, 
2008). This combined explanation is directly supported 
by our result that when Ni2+ was added to the low Ca2+ 
solution, the rate of decay of the Ca2+ transient was sig-
nificantly retarded but not completely restored (Fig. 5). 
It is important to point out that the sarcolemma is not 
permeable to Ni2+, and when it is present it blocks the 
inward Ca2+ current during depolariz­ation of amphib-
ian skeletal muscle fibers (Palade and Almers, 1985). 
In this regard, we have found that 2 mM Ni2+ blocks the 
L-type Ca2+ current in both WT and R163C myotubes 
(unpublished data) and divalent cation entry during 
depolariz­ation (Fig. 6). Interestingly, we found the con-
tribution of extracellular Ca2+ to be more substantial in 
both Hom and Het R163C myotubes than in WT.
Exposure of WT and R163C myotubes to the L-type 
Ca2+ channel antagonist nifedipine or the nonspecific 
cation channel blocker SKF-96365 also accelerated the 
rate of decline of Ca2+ transients (Fig. 4) in the pres-
ence of extracellular Ca2+. The fact that we did not ob-
serve a significant reduction in the peak Ca2+ transient 
amplitude in either WT or R163C myotubes shows that 
peak Ca2+ transient amplitude is largely controlled by 
SR Ca2+ release, and the brief exposure to both drugs 
prevented any secondary effects of these drugs. Although 
both drugs are known to block Ca2+ entry via the DHPR 
(Bannister et al., 2009), nifedipine caused a more rapid 
decline in the Ca2+ transient because it also alters the 
inactivation of the DHPR voltage sensor.
The general model for ECC suggests that Ca2+ release 
in skeletal muscle is controlled by a voltage sensor, which 
threshold for [K+]e was lower in MHS than in WT pig 
skeletal muscle fibers.
Interestingly, the rate of decay of the Ca2+ transient 
elicited by [K+]e was slower in Hom and Het R163C 
compared with WT myotubes. Our data show that the 
decay in the peak of the Ca2+ transient during mem-
brane depolariz­ation observed in WT and R163C myo-
tubes is related neither to SR Ca2+ depletion (Hodgkin 
and Horowicz­, 1960b) nor to inactivation of RYR1 due 
to the high Ca2+ present in the myoplasm (Smith et al., 
1985; Suarez­-Isla et al., 1986; Simon et al., 1991; Jong et al., 
1995) because the application of 20 mM caffeine was 
able to induce a robust Ca2+ release in all genotypes at 
all time points during the decay phase of the Ca2+ tran-
sient during the prolonged K+ depolariz­ation (Fig. 2). 
The most probable explanation for this observation is 
that an alteration in the conformation of the RYR1 tet-
ramer caused by even one MHS allele affects both or-
thograde and retrograde coupling between the DHPR 
and RYR1 (Nakai et al., 1996, 1998). Specifically, our 
data demonstrate at least two retrograde effects of the 
R163C mutation on DHPRs that alter the properties of 
ECC. The first is that the threshold for activation of Ca2+ 
release induced by [K+]e is lowered by the RYR1 MH 
mutation (this change is confirmed electrophysiologi-
cally in the companion paper [see Bannister et al. in 
this issue]). Second, the R163C RyR1 mutation slows 
the rate of inactivation of the DHPR voltage sensor for 
ECC (Figs. 1 and 7). Additionally, our data suggest that 
the R163C mutation increases Ca2+ entry during pro-
longed depolariz­ation.
Previous reports have shown that skeletal muscle fibers 
can contract after electrical stimulation or under whole 
cell voltage clamp with short step depolariz­ations in low 
extracellular Ca2+ concentrations (Armstrong et al., 1972; 
Bolaños et al., 1986). However, the importance of extra-
cellular Ca2+ both in the presence (Lüttgau and Spiecker, 
1979; Caputo, 1981; Cota and Stefani, 1981) and ab-
sence of Ca2+ buffers (Caputo and Gimenez­, 1967; 
Lüttgau and Spiecker, 1979) for maintenance of muscle 
K+ contractures has also been well demonstrated. Our 
data provide evidence that external Ca2+ plays a signifi-
cant physiological role for the maintenance of Ca2+ 
transients induced by elevated [K+]e in WT and R163C 
MHS myotubes (Fig. 3). In fact, the duration of the Ca2+ 
transient was shortened (increased rate of decay of peak 
Ca2+) in nominally Ca2+-free external solution or in the 
presence of Ca2+ entry blockers (Figs. 3 and 4) regard-
less of genotype. We have ruled out the possibility that 
the increased rate of decay in the presence of low [Ca2+]e 
might be a consequence of reduced SR Ca2+ content 
resulting from prolonged membrane depolariz­ation 
(Hodgkin and Horowicz­, 1960a,b; Caputo and Gimenez­, 
1967), as the addition of 5 mM Mg2+ to the external so-
lutions prevents this depolariz­ation (unpublished data; 
see Materials and methods). Furthermore, if resting SR 
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is an integral function of the DHPR that initially activates 
and subsequently inactivates to tightly control SR Ca2+ re-
lease. Furthermore, it is known that the time course of 
K+-triggered contractures is determined by the onset and 
time course of the voltage sensor inactivation process 
(Caputo, 1976; Bolaños et al., 1986), which is initiated 
immediately after activation begins (Caputo, 1972a,b). 
From the experiments in which Ni2+ was substituted for 
Ca2+, it was shown that depolariz­ation-induced Ca2+ entry 
is enhanced in Het and Hom R163C, but the majority of 
the difference in the rate of decay of the Ca2+ transient in 
Het and Hom R163C myotubes is due to prolonged SR 
Ca2+ release caused by either a delay in the onset or a re-
duction in the rate of DHPR voltage sensor inactivation.
The double K+ application protocol (Fig. 7) con-
firmed this idea by demonstrating that the second Ca2+ 
transient of the pair was significantly smaller in WT 
myotubes than in R163C myotubes with all delays. Fur-
thermore, the rate of decay of the Ca2+ transient was 
slower in Hom than in Het R163C myotubes, suggesting 
that the conformation of R163C has a significant im-
pact through retrograde signaling from RYR1 to the 
DHPR on the voltage sensor inactivation process, in ad-
dition to the retrograde signals that control L-type Ca2+ 
current. In the companion paper (Bannister et al., 
2010), we have examined the effects of the R163C mu-
tation in RYR1 on the biophysical properties of the skel-
etal muscle L-type Ca2+ channel.
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